Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Raj Shah

Concepts (349)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cholangiopancreatography, Endoscopic Retrograde
47
2026
223
10.150
 Why?
Endoscopy, Digestive System
24
2026
142
7.130
 Why?
Pancreatic Ducts
23
2025
82
6.850
 Why?
Pancreatic Diseases
14
2024
66
4.700
 Why?
Pancreatitis, Chronic
12
2024
64
4.400
 Why?
Calculi
8
2022
16
3.840
 Why?
Bile Duct Neoplasms
13
2021
131
3.310
 Why?
Endosonography
25
2024
160
3.300
 Why?
Stents
21
2025
564
3.160
 Why?
Lithotripsy
11
2024
49
3.150
 Why?
Cholangitis, Sclerosing
8
2022
61
2.760
 Why?
Pancreatic Neoplasms
20
2024
928
2.490
 Why?
Cholangiocarcinoma
7
2021
108
2.380
 Why?
Bile Ducts
10
2025
68
2.000
 Why?
Drainage
10
2024
185
1.960
 Why?
Bile Ducts, Intrahepatic
5
2021
63
1.880
 Why?
Cholestasis
8
2025
214
1.830
 Why?
Constriction, Pathologic
16
2025
249
1.810
 Why?
Biliary Tract Surgical Procedures
4
2021
28
1.730
 Why?
Endoscopy, Gastrointestinal
12
2023
237
1.690
 Why?
Gallstones
5
2026
35
1.470
 Why?
Laser Therapy
2
2025
144
1.270
 Why?
Pancreatic Pseudocyst
5
2024
18
1.250
 Why?
Microscopy, Confocal
8
2021
319
1.210
 Why?
Pancreas
6
2021
341
1.170
 Why?
Biliary Tract Diseases
4
2016
33
1.160
 Why?
Endoscopes
3
2017
17
1.040
 Why?
Aged
53
2026
26153
1.010
 Why?
Middle Aged
61
2026
36215
0.990
 Why?
Treatment Outcome
31
2025
11772
0.970
 Why?
Carcinoma, Pancreatic Ductal
5
2016
293
0.950
 Why?
Retrospective Studies
31
2025
17291
0.890
 Why?
Adenocarcinoma
7
2023
925
0.840
 Why?
Pancreatitis
5
2024
146
0.830
 Why?
Endoscopy
4
2015
317
0.820
 Why?
Endoscopic Ultrasound-Guided Fine Needle Aspiration
7
2019
61
0.820
 Why?
Endoscopes, Gastrointestinal
8
2013
13
0.820
 Why?
Humans
110
2026
145474
0.800
 Why?
Common Bile Duct Neoplasms
1
2023
28
0.790
 Why?
Duodenal Neoplasms
1
2023
26
0.790
 Why?
Ampulla of Vater
1
2023
40
0.780
 Why?
Choledochal Cyst
2
2020
17
0.780
 Why?
Laparoscopy
4
2021
481
0.760
 Why?
Male
66
2026
72842
0.750
 Why?
Hepatic Encephalopathy
1
2022
25
0.740
 Why?
Female
68
2026
78844
0.740
 Why?
Adenocarcinoma, Mucinous
2
2016
76
0.730
 Why?
Gastrointestinal Tract
1
2025
204
0.720
 Why?
Catheterization
8
2024
183
0.720
 Why?
Portasystemic Shunt, Transjugular Intrahepatic
1
2022
38
0.710
 Why?
Adenoma
2
2023
218
0.710
 Why?
Hypertension, Portal
1
2022
66
0.700
 Why?
Pancreatectomy
3
2021
289
0.700
 Why?
Cholangitis
1
2022
22
0.700
 Why?
End Stage Liver Disease
1
2022
95
0.660
 Why?
Calcinosis
2
2019
234
0.630
 Why?
Cytodiagnosis
1
2020
31
0.630
 Why?
Intestine, Small
2
2019
167
0.600
 Why?
In Situ Hybridization, Fluorescence
1
2020
325
0.580
 Why?
Adult
37
2026
40777
0.550
 Why?
Lithotripsy, Laser
2
2015
4
0.550
 Why?
Aged, 80 and over
18
2025
8333
0.530
 Why?
Aneurysm, False
1
2018
46
0.530
 Why?
Quality of Life
4
2024
3204
0.530
 Why?
Foreign Bodies
1
2018
110
0.510
 Why?
Disposable Equipment
1
2017
24
0.510
 Why?
Prospective Studies
23
2024
8057
0.510
 Why?
Artificial Intelligence
1
2022
381
0.510
 Why?
Liver Neoplasms
1
2023
776
0.500
 Why?
Polyethylene
1
2016
13
0.470
 Why?
Biopsy
6
2018
1082
0.470
 Why?
Follow-Up Studies
13
2025
5423
0.470
 Why?
Gallbladder Diseases
1
2015
11
0.460
 Why?
Gastroenterology
4
2019
191
0.450
 Why?
Pancreatic Juice
1
2014
3
0.430
 Why?
Gastrointestinal Diseases
5
2022
221
0.430
 Why?
Learning Curve
5
2019
71
0.430
 Why?
Sphincterotomy, Endoscopic
4
2019
29
0.420
 Why?
Biomarkers, Tumor
2
2014
1321
0.410
 Why?
Metals
4
2023
136
0.410
 Why?
CA-19-9 Antigen
1
2014
34
0.410
 Why?
Sensitivity and Specificity
9
2021
1997
0.400
 Why?
Postoperative Complications
3
2022
2970
0.390
 Why?
Cholestasis, Intrahepatic
1
2013
29
0.380
 Why?
Hemorrhage
1
2018
822
0.370
 Why?
Ultrasonography, Interventional
3
2022
165
0.360
 Why?
Pancreatitis, Acute Necrotizing
2
2023
14
0.360
 Why?
Predictive Value of Tests
7
2017
2121
0.350
 Why?
Anastomosis, Roux-en-Y
2
2022
26
0.340
 Why?
Liver Diseases
1
2014
305
0.340
 Why?
Biliary Tract Neoplasms
3
2016
31
0.320
 Why?
Young Adult
9
2025
14218
0.320
 Why?
Clinical Competence
5
2019
1243
0.310
 Why?
Foreign-Body Migration
2
2006
33
0.280
 Why?
Natural Orifice Endoscopic Surgery
3
2018
35
0.280
 Why?
Pancreatic Cyst
3
2018
50
0.270
 Why?
Needles
3
2019
63
0.270
 Why?
B7-1 Antigen
1
2008
55
0.270
 Why?
Gastrointestinal Hemorrhage
2
2008
138
0.270
 Why?
Video Recording
4
2016
217
0.260
 Why?
Fluorouracil
4
2020
231
0.250
 Why?
Bile Ducts, Extrahepatic
2
2020
20
0.250
 Why?
Gallbladder
2
2022
15
0.250
 Why?
Dilatation
2
2018
71
0.250
 Why?
Abdominal Pain
4
2023
149
0.240
 Why?
Cholelithiasis
3
2015
36
0.230
 Why?
Adolescent
11
2025
22529
0.230
 Why?
Autonomic Nerve Block
1
2024
10
0.220
 Why?
Celiac Plexus
1
2024
7
0.220
 Why?
Hemostatic Techniques
1
2005
52
0.220
 Why?
Indomethacin
1
2024
76
0.210
 Why?
Catheters
2
2015
74
0.210
 Why?
Peritoneal Neoplasms
1
2005
104
0.210
 Why?
Guanidines
1
2023
39
0.200
 Why?
Tumor Suppressor Protein p53
1
2008
534
0.200
 Why?
Ambulatory Care Facilities
1
2006
269
0.200
 Why?
Equipment Design
9
2013
525
0.200
 Why?
Esters
1
2023
71
0.200
 Why?
Prosthesis Implantation
2
2019
154
0.190
 Why?
Cholecystitis, Acute
1
2022
26
0.180
 Why?
Self Expandable Metallic Stents
1
2022
17
0.180
 Why?
Choledochostomy
1
2022
10
0.180
 Why?
Pain
3
2022
789
0.180
 Why?
Pain Measurement
1
2024
561
0.180
 Why?
Plastics
2
2022
50
0.180
 Why?
Analgesics, Opioid
2
2024
1149
0.180
 Why?
Multiple Myeloma
1
2005
309
0.170
 Why?
Multivariate Analysis
3
2021
1547
0.170
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2024
345
0.170
 Why?
Antimetabolites, Antineoplastic
2
2020
106
0.170
 Why?
Multicenter Studies as Topic
1
2022
412
0.160
 Why?
United States
9
2017
16098
0.160
 Why?
Lasers
1
2021
126
0.160
 Why?
Tegafur
1
2020
12
0.160
 Why?
Oxonic Acid
1
2020
13
0.160
 Why?
Fluoroscopy
4
2026
180
0.150
 Why?
Logistic Models
3
2021
2134
0.150
 Why?
Dissection
2
2018
57
0.150
 Why?
Living Donors
1
2022
282
0.150
 Why?
Randomized Controlled Trials as Topic
4
2022
1747
0.150
 Why?
Fiducial Markers
1
2019
9
0.150
 Why?
Hydrogen Peroxide
1
2021
335
0.150
 Why?
Urinary Calculi
1
2019
10
0.150
 Why?
Carcinoma, Squamous Cell
1
2004
641
0.150
 Why?
ROC Curve
2
2018
617
0.150
 Why?
Carcinoembryonic Antigen
2
2018
40
0.150
 Why?
Radiotherapy, Image-Guided
1
2019
39
0.150
 Why?
Severity of Illness Index
2
2022
2930
0.140
 Why?
Reproducibility of Results
4
2019
3413
0.140
 Why?
Anastomosis, Surgical
1
2019
162
0.140
 Why?
Lasers, Solid-State
1
2018
22
0.140
 Why?
Risk Factors
6
2024
10885
0.140
 Why?
Journal Impact Factor
1
2018
29
0.140
 Why?
Cystadenoma, Serous
1
2018
18
0.130
 Why?
Gastric Outlet Obstruction
1
2017
12
0.130
 Why?
Cholecystectomy, Laparoscopic
1
2018
55
0.130
 Why?
Fiber Optic Technology
2
2015
23
0.130
 Why?
Hospitals, University
1
2018
176
0.130
 Why?
Diagnosis, Differential
3
2015
1508
0.130
 Why?
Parkinsonian Disorders
1
2017
43
0.130
 Why?
Gastrointestinal Neoplasms
2
2008
73
0.130
 Why?
Urinary Incontinence
1
2017
65
0.130
 Why?
Narrow Band Imaging
1
2016
14
0.120
 Why?
Neoplasm Recurrence, Local
1
2023
1149
0.120
 Why?
Education, Medical, Graduate
2
2019
562
0.120
 Why?
Feasibility Studies
4
2018
1111
0.120
 Why?
Regression Analysis
1
2018
1001
0.120
 Why?
Neuroendocrine Tumors
1
2018
119
0.120
 Why?
Time Factors
3
2019
7123
0.120
 Why?
Reoperation
1
2019
633
0.120
 Why?
Gastric Bypass
1
2017
126
0.120
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2016
27
0.120
 Why?
Neoplasm Staging
6
2013
1471
0.110
 Why?
Cystadenoma, Mucinous
1
2015
11
0.110
 Why?
Periodicals as Topic
1
2018
209
0.110
 Why?
Cystadenocarcinoma, Mucinous
1
2015
12
0.110
 Why?
Pathology, Clinical
1
2015
29
0.110
 Why?
Radio Waves
1
2015
28
0.110
 Why?
Single-Blind Method
1
2016
318
0.110
 Why?
Fellowships and Scholarships
1
2019
354
0.110
 Why?
Pancreaticoduodenectomy
1
2016
137
0.110
 Why?
Incidence
2
2018
2923
0.100
 Why?
Europe
1
2014
418
0.100
 Why?
Tertiary Care Centers
1
2014
195
0.100
 Why?
Double-Balloon Enteroscopy
1
2013
1
0.100
 Why?
Disinfection
2
2018
131
0.100
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2013
1963
0.100
 Why?
Length of Stay
1
2019
1349
0.100
 Why?
Databases, Factual
1
2018
1490
0.090
 Why?
Cyst Fluid
2
2018
20
0.090
 Why?
Colonoscopy
2
2018
263
0.090
 Why?
Academic Medical Centers
2
2017
554
0.080
 Why?
Carcinoma
1
2013
225
0.080
 Why?
Technology Assessment, Biomedical
2
2008
44
0.080
 Why?
Chemoradiotherapy
1
2013
239
0.080
 Why?
Deoxycytidine
2
2013
220
0.080
 Why?
Biopsy, Fine-Needle
2
2008
68
0.080
 Why?
Cohort Studies
2
2014
6013
0.080
 Why?
Esophageal Neoplasms
2
2005
348
0.080
 Why?
Catheter Ablation
1
2015
355
0.080
 Why?
Parkinson Disease
1
2017
599
0.080
 Why?
Referral and Consultation
2
2016
867
0.080
 Why?
Antibiotic Prophylaxis
1
2012
134
0.080
 Why?
Child
4
2018
22707
0.080
 Why?
Radiography
1
2013
852
0.080
 Why?
Practice Guidelines as Topic
1
2018
1581
0.080
 Why?
Minimally Invasive Surgical Procedures
2
2008
189
0.080
 Why?
Colorado
2
2018
4553
0.070
 Why?
Abdominal Abscess
1
2009
26
0.070
 Why?
Colonography, Computed Tomographic
1
2009
8
0.070
 Why?
Intestinal Perforation
1
2008
46
0.070
 Why?
Capsule Endoscopy
1
2008
25
0.070
 Why?
Decompression, Surgical
1
2009
116
0.070
 Why?
Risk Assessment
4
2016
3747
0.070
 Why?
Prognosis
3
2016
4316
0.070
 Why?
Duodenum
1
2008
77
0.070
 Why?
Gastric Mucosa
1
2008
54
0.070
 Why?
V-Set Domain-Containing T-Cell Activation Inhibitor 1
1
2008
6
0.070
 Why?
Tissue Fixation
1
2008
37
0.070
 Why?
NAD(P)H Dehydrogenase (Quinone)
1
2008
36
0.070
 Why?
Palliative Care
2
2009
1020
0.070
 Why?
Equipment Safety
4
2008
38
0.070
 Why?
Wounds, Penetrating
1
2008
72
0.070
 Why?
Balloon Occlusion
1
2008
39
0.070
 Why?
Immunoenzyme Techniques
1
2008
200
0.070
 Why?
Medical Records Systems, Computerized
1
2008
95
0.070
 Why?
Coloring Agents
1
2007
89
0.060
 Why?
Radiotherapy, Intensity-Modulated
1
2008
142
0.060
 Why?
Image Enhancement
1
2008
200
0.060
 Why?
Rectal Neoplasms
1
2008
159
0.060
 Why?
Duodenoscopy
1
2006
8
0.060
 Why?
Liver
2
2005
1896
0.060
 Why?
Laser Coagulation
1
2006
80
0.060
 Why?
Prosthesis Design
2
2009
354
0.060
 Why?
Intestinal Mucosa
2
2008
675
0.060
 Why?
Tomography, X-Ray Computed
2
2014
2769
0.060
 Why?
Anesthesia, General
1
2006
120
0.060
 Why?
Radiation Exposure
1
2026
63
0.060
 Why?
Operative Time
1
2026
181
0.060
 Why?
Ascites
1
2005
48
0.060
 Why?
Thoracic Neoplasms
1
2005
39
0.060
 Why?
Acute Disease
1
2008
1036
0.050
 Why?
Administration, Rectal
1
2024
14
0.050
 Why?
Equipment Failure
1
2005
115
0.050
 Why?
Growth Substances
1
2004
138
0.050
 Why?
Radiotherapy, Adjuvant
3
2013
222
0.050
 Why?
Pain Management
1
2008
410
0.050
 Why?
Immunoglobulin A
1
2005
214
0.050
 Why?
Liver Cirrhosis
1
2006
287
0.050
 Why?
Infant
1
2018
10077
0.050
 Why?
Chemotherapy, Adjuvant
3
2013
423
0.050
 Why?
International Cooperation
2
2017
197
0.050
 Why?
Child, Preschool
1
2018
11853
0.050
 Why?
Neoplasm Metastasis
1
2005
688
0.050
 Why?
Diagnostic Tests, Routine
1
2003
107
0.050
 Why?
Necrosis
1
2023
244
0.040
 Why?
Pilot Projects
1
2008
1891
0.040
 Why?
Odds Ratio
2
2016
1082
0.040
 Why?
Polycystic Kidney, Autosomal Dominant
1
2004
235
0.040
 Why?
Combined Modality Therapy
3
2013
1266
0.040
 Why?
Anti-Infective Agents, Local
1
2021
40
0.040
 Why?
Disease-Free Survival
2
2013
767
0.040
 Why?
Drug Combinations
1
2020
396
0.040
 Why?
Double-Blind Method
1
2023
2062
0.040
 Why?
Kaplan-Meier Estimate
2
2013
969
0.030
 Why?
Myotomy
1
2018
15
0.030
 Why?
Equipment Contamination
1
2018
67
0.030
 Why?
Republic of Korea
1
2017
43
0.030
 Why?
Endoscopic Mucosal Resection
1
2018
38
0.030
 Why?
Surgical Instruments
1
2018
51
0.030
 Why?
Administration, Oral
1
2020
866
0.030
 Why?
Bile
2
2009
26
0.030
 Why?
Autopsy
1
2017
94
0.030
 Why?
Surgery, Computer-Assisted
1
2018
85
0.030
 Why?
Prosthesis Failure
2
2009
125
0.030
 Why?
Colonic Polyps
1
2018
87
0.030
 Why?
Cytokines
1
2004
2067
0.030
 Why?
United Kingdom
1
2017
344
0.030
 Why?
Videotape Recording
1
2016
37
0.030
 Why?
Gastroenterologists
1
2016
21
0.030
 Why?
Hospitalization
1
2006
2460
0.030
 Why?
Quality Indicators, Health Care
1
2018
336
0.030
 Why?
Barrett Esophagus
1
2018
169
0.030
 Why?
Geriatric Assessment
1
2017
239
0.030
 Why?
Radiologists
1
2016
61
0.030
 Why?
Watchful Waiting
1
2016
90
0.030
 Why?
Surveys and Questionnaires
1
2008
6066
0.030
 Why?
Phantoms, Imaging
1
2016
159
0.030
 Why?
Disease Management
1
2018
653
0.030
 Why?
Societies, Medical
2
2008
899
0.030
 Why?
Inflammatory Bowel Diseases
1
2018
364
0.020
 Why?
Organoplatinum Compounds
1
2013
65
0.020
 Why?
Leucovorin
1
2013
98
0.020
 Why?
Injections, Intralesional
1
2013
35
0.020
 Why?
Erlotinib Hydrochloride
1
2013
72
0.020
 Why?
Program Evaluation
1
2017
943
0.020
 Why?
Camptothecin
1
2013
138
0.020
 Why?
Comorbidity
1
2017
1661
0.020
 Why?
Treatment Failure
1
2013
360
0.020
 Why?
False Negative Reactions
1
2011
61
0.020
 Why?
Quinazolines
1
2013
266
0.020
 Why?
False Positive Reactions
1
2011
123
0.020
 Why?
Drug Administration Schedule
1
2013
782
0.020
 Why?
Neoadjuvant Therapy
1
2013
465
0.020
 Why?
Colorectal Neoplasms
1
2018
866
0.020
 Why?
Longitudinal Studies
1
2017
2953
0.020
 Why?
Stainless Steel
1
2009
19
0.020
 Why?
Alloys
1
2009
37
0.020
 Why?
Hematoma
1
2009
63
0.020
 Why?
Terminally Ill
1
2009
40
0.020
 Why?
Observer Variation
1
2010
357
0.020
 Why?
Medical Laboratory Science
1
2008
9
0.020
 Why?
Rupture
1
2008
91
0.020
 Why?
Miniaturization
1
2008
22
0.020
 Why?
Ligation
1
2008
91
0.020
 Why?
Probability
1
2009
307
0.020
 Why?
Capecitabine
1
2008
56
0.020
 Why?
Premedication
1
2008
45
0.020
 Why?
Total Quality Management
1
2008
57
0.020
 Why?
Evaluation Studies as Topic
1
2008
164
0.020
 Why?
Forms and Records Control
1
2008
20
0.020
 Why?
Esophageal and Gastric Varices
1
2008
36
0.020
 Why?
Radiotherapy Dosage
1
2008
288
0.020
 Why?
Morbidity
1
2008
322
0.020
 Why?
Remission Induction
1
2008
307
0.020
 Why?
Biopsy, Needle
1
2007
185
0.020
 Why?
Safety Management
1
2008
125
0.020
 Why?
Diarrhea
1
2008
193
0.020
 Why?
Injections
1
2007
199
0.020
 Why?
Costs and Cost Analysis
1
2007
221
0.020
 Why?
DNA
1
2013
1435
0.010
 Why?
Survival Analysis
1
2009
1374
0.010
 Why?
Information Dissemination
1
2008
224
0.010
 Why?
Safety
1
2007
358
0.010
 Why?
Prostheses and Implants
1
2006
137
0.010
 Why?
Patient Selection
1
2009
738
0.010
 Why?
Receptors, Interleukin-8B
1
2004
29
0.010
 Why?
Obesity
1
2018
3116
0.010
 Why?
Esophagectomy
1
2005
135
0.010
 Why?
Recurrence
1
2007
1138
0.010
 Why?
Survival Rate
1
2008
2090
0.010
 Why?
Swine
1
2006
825
0.010
 Why?
Positron-Emission Tomography
1
2005
343
0.010
 Why?
Ischemia
1
2004
422
0.010
 Why?
Epithelial Cells
1
2004
1131
0.010
 Why?
Cells, Cultured
1
2004
4148
0.010
 Why?
Biomarkers
1
2008
4295
0.010
 Why?
Disease Models, Animal
1
2006
4560
0.010
 Why?
Animals
1
2006
38030
0.000
 Why?
Shah's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (349) concept(s)
_
Co-Authors Expand Description
See all (23) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)